Regeneron Pharmaceuticals, Inc. (LON:0R2M)
591.42
-0.58 (-0.10%)
At close: Apr 24, 2025
Regeneron Pharmaceuticals Revenue
In the year 2024, Regeneron Pharmaceuticals had annual revenue of $14.20B USD with 8.27% growth. Regeneron Pharmaceuticals had revenue of $3.79B in the quarter ending December 31, 2024, with 10.33% growth.
Revenue
$14.20B
Revenue Growth
+8.27%
P/S Ratio
4.27
Revenue / Employee
$940.16K
Employees
15,106
Market Cap
48.46B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.20B | 1.08B | 8.27% |
Dec 31, 2023 | 13.12B | 944.30M | 7.76% |
Dec 31, 2022 | 12.17B | -3.90B | -24.26% |
Dec 31, 2021 | 16.07B | 7.57B | 89.14% |
Dec 31, 2020 | 8.50B | 1.94B | 29.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Regeneron Pharmaceuticals News
- 11 days ago - Biocon Biologics' Yesafili to enter US market, after agreement with Regeneron - The Times of India
- 11 days ago - Biocon shares jump 3% as its subsidiary secures US market entry for Yesafili - Business Upturn
- 11 days ago - Biocon Biologics secures U.S. market entry for Yesafili™, an interchangeable biosimilar to Eylea® - Business Upturn
- 11 days ago - Trump says US pharma tariffs coming in not-too-distant future - Reuters
- 14 days ago - Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages - CNBC
- 15 days ago - Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
- 16 days ago - Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback - CNBC
- 16 days ago - Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out - Seeking Alpha